Whitepaper: Understanding the Role of Spore-Based Bacteriotherapy in Metabolic Endotoxemia

April 13, 2017

urlby Kiran Krishnan, Microbiologist and Clinical Researcher

Bacteria were largely considered a threat for generations of doctors, but, in recent decades, science has discovered that the bacteria living in our gut are crucial to human health. The number and diversity of microbes that colonize in a person’s gut can influence weight gain or weight loss, clogged or clear arteries, diabetes risk, and mood. Today, medical research is not just focused on developing antibiotics for infections, but also strives to develop probiotics that cultivate optimal gut microbe populations.

However, cultivating the right bacterial strains that can survive both in a factory and in the gut is a challenging task. Kiran Krishnan, a microbiologist and clinical researcher, has investigated probiotics for more than 15 years. From his experience, he explains why probiotics aimed at fighting metabolic endotoxemia—instead of digestion or diarrhea issues—should take priority in probiotic research. He also explains why bacterial spores, and not the bacteria found in conventional probiotics today, make the most effective probiotic product.

This whitepaper will discuss fundamental features of probiotics and bacterial spores, as well as how to fight endotoxemia with bacteria.

Thank you! You should be receiving an email shortly with your content.